Signaling through the ErbB family of tyrosine kinase receptors in normal and cancer-derived cell lines contributes to cell growth and differentiation. In this work, we altered the levels of ErbB2 and ErbB3 receptors, individually and in combination, by using 6-finger and 12-finger synthetic zinc finger protein artificial transcription factors (ATFs) in an epidermoid squamous cell carcinoma line, A431. We successfully designed 12-finger ATFs capable of coregulating ErbB3 and ICAM-1 or ErbB2 and ErbB3. With ATFs, the effects of changes in ErbB2 and ErbB3 receptor levels were evaluated by using cell proliferation, cell migration, and cell signaling assays. Cell proliferation was increased when ErbB2 and ErbB3 were both overexpressed. Cell migration on collagen was decreased when ErbB2 was down-regulated, yet migration on laminin was significantly increased with ErbB3 overexpression. ErbB2 and ErbB3 overexpression also stimulated the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Our ATF approach has elucidated differences in ErbB receptor-mediated proliferation, migration, and intracellular signaling that cannot be explained merely by the presence or absence of particular ErbB receptors and emphasizes the dynamic nature of the ErbB signaling system. The transcription factor approach developed here provides a gene-economical route to the regulation of multiple genes and may be important for complex gene therapies.Signaling from ErbB tyrosine kinase receptors influences diverse aspects of a cell's biology that include growth, differentiation, migration, and apoptosis (29, 84). ErbB1 (EGFR/ HER1) was the first member of the family identified. Based on homology to ErbB1, three additional family members, ErbB2 (HER2/p185), ErbB3 (HER3), and ErbB4 (HER4), were identified (41,56,60,77). In normal development, binding of a growth factor ligand induces dimerization of ErbB receptors. Subsequently, the cytoplasmic tails are transphosphorylated. Each ErbB receptor has a unique pattern of phosphorylation sites that recruit various secondary signaling proteins (23,51,52,55,71). Ongoing research shows that the identity of the ligand bound, the amount of ligand, and the identities of dimers formed determine the activation of a particular intracellular signaling pathway such as the mitogen-activated protein kinase (MAPK), the stress-activated protein kinase, the protein kinase C, or the Akt pathway (53,61,72). The combination of at least 10 different ligands and 10 possible receptor dimers of the ErbB system form a signaling network essential for development (15,34).Various cancers, including those of the breast, head and neck, kidney, prostate, colon, pancreas, bladder, lung, and ovaries, are associated with overexpression of ErbB receptors (11,59,84). Research using breast cancer models has identified a dominant role for ErbB2 in tumor cell proliferation and metastasis (35,64,73,74). ErbB2 is the preferred dimerization partner for all ErbB receptors, and dimers containing ErbB2 have higher ligand af...